Last edition
News about "Chris Fox"
Teva Wins US FDA Approval for Monthly Olanzapine Injection
Teva has announced US FDA approval of WELTRUZA for ER injectable suspension, as the first and only once-monthly subcutaneous injectable polanzapine for adults.
Chris Fox | 12/10/2026 | By News Bureau
Teva Pharma and Trump Administration Plan Agreement on Affordable Medicines
Teva Pharma plans an agreement with the Trump Administration to align US Medicaid pricing for select medicines with leading developed markets under the GENEROUS framework.
Chris Fox | 02/09/2026 | By News Bureau | 112
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy